Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (3297 companies, A–Z).
Faraday Future issued one share of newly created Series A Preferred Stock to Executive Chairman Jiawei Wang for $100 on November 4, 2026. The share gives Wang 500,000,000 votes, but only on a proposed reverse stock split, so it strengthens the chairman's influence over that vote and changes the approval threshold for it.
One Series A Preferred share sold to Executive Chairman Jiawei Wang for $100.00, closed November 4, 2026.
The share carries 500,000,000 votes, limited to the Reverse Stock Split Proposal, and mirrors votes cast by common stockholders.
The share is redeemed for $100.00 automatically upon stockholder approval of the reverse split, or earlier at the Board's discretion.
Approval of the reverse split now requires a majority of combined voting power, including the Series A share.
Jaguar Health held a special meeting of stockholders on November 6, 2026, and all six proposals were approved. The approvals cover a reverse stock split at a ratio between 1-for-2 and 1-for-150, to be set by the board, and a reduction in the floor price of an equity line agreement with C/M Capital from $16.50 to $1.10 per share. The reverse split was approved under the Votes Cast Standard but not under the Majority of Outstanding Standard, as the filing notes.
Special meeting held November 6, 2026; 3,383,169 of 7,802,102 shares of common stock outstanding as of the September 15, 2026 record date were represented.
Reverse stock split approved at a ratio of not less than 1-for-2 and not greater than 1-for-150; the board will set the exact ratio and announce it within one year.
Reverse split vote was 3,551,428 for and 222,394 against, but not approved under the Majority of Outstanding Standard.
ELOC Agreement floor price cut from $16.50 to $1.10 per share; 2,400,107 votes for and 158,386 against.
Liberty Media acquired 2,316,537 high-vote Series B shares from John Malone-related entities in exchange for low-vote Series A and non-voting Series C shares, cutting the Malone Holders' voting power to approximately 3% from approximately 48%. The board also adopted a shareholder rights plan with a $426.00 purchase price, which the filing says may make an unapproved takeover more difficult.
Malone Holders exchanged 2,316,537 Series B shares, which were cancelled and retired, for 602,302 Series A and 5,420,699 Series C shares, with the exchange closing November 4, 2026
Malone Holders' voting power fell to approximately 3% from approximately 48%, and no holder now has more than 9% of voting power as of October 30, 2026
Rights are attached to common stock with a $426.00 purchase price, a record date of November 16, 2026, and an expiration of November 3, 2027
Malone stepped down as Chairman Emeritus and will serve as Senior Advisor under an amended employment agreement
On November 4, 2026, Summit Therapeutics stockholders approved raising authorized common shares from 1 billion to 2 billion at a special meeting, and the amendment took effect when filed that day. The same day, the company reported third-quarter 2026 results showing a GAAP net loss of $208.4 million ($0.26 per share), narrower than $231.8 million a year earlier, while the non-GAAP net loss widened to $160.7 million from $101.0 million. Cash and short-term investments were $629.8 million at September 30, 2026, and the $2.0 billion AstraZeneca equity investment completed October 5, 2026, after the quarter ended.
Amendment No. 3 increases authorized common stock by 1,000,000,000 shares to 2,000,000,000; votes for were 658,142,561, against 1,983,511, with 3,134,826 abstentions.
GAAP net loss was $208.4 million, or $(0.26) per share, versus $231.8 million, or $(0.31) per share, a year earlier; non-GAAP net loss was $160.7 million, or $(0.20) per share, versus $101.0 million, or $(0.13).
Cash and short-term investments were $629.8 million at September 30, 2026, down from $713.4 million at December 31, 2025; the company raised $94.1 million through its ATM facility in the third quarter.
AstraZeneca completed a $2.0 billion strategic equity investment on October 5, 2026; the FDA PDUFA goal action date for the ivonescimab BLA is November 14, 2026.
Comstock reported a third quarter 2026 net loss of $0.8 million, or $(0.01) per share, which included a $14.0 million gain from the August 21, 2026 sale of its remaining mining assets. The Board also authorized a share repurchase program of up to 15 million shares, about 19.7% of outstanding common stock, with no obligation to buy any particular number of shares.
Q3 2026 net loss of $0.8 million, or $(0.01) per share, including a $14.0 million gain on the mining asset sale
Metals Segment revenue rose to $341,751 in Q3 2026, up 45.4% from $235,074 in Q2 2026
Cash, cash equivalents and restricted cash totaled $43.5 million at quarter end, with no outstanding debt
Board authorized repurchases of up to 15 million shares on November 2, 2026; the program may be modified, suspended or discontinued at any time
Adient's board adopted a Tax Benefits Preservation Plan to help protect its U.S. net operating loss carryforwards and other tax attributes, and increased its share repurchase authorization by $400 million to a total of $1 billion. The rights plan is designed to make it harder for any person or group to reach a 4.95% stake, which could limit a takeover or large holder purchase, while the larger buyback authorization gives the company more capacity to return capital to shareholders.
The company's rights are issued one per ordinary share, exercisable after the Separation Time for $83.50 to buy one one-thousandth of a participating preferred share.
The repurchase authorization rises by $400 million to $1 billion total, with $435 million remaining after $565 million repurchased under the program launched in November 2022.
The plan expires on November 4, 2027 unless shareholders ratify it, in which case it runs to November 4, 2029; the company intends to seek shareholder approval at its next annual meeting.
On October 27, 2026, SkyAI, Inc. entered into a tender support and settlement agreement with Bastion Trading Limited, a major stockholder, and amended its ongoing cash tender offer. The amended offer raises the purchase of pre-funded warrants to 100% of each class from 95%, adds stapled warrants at $0.17 each, and extends the offer to November 12, 2026. If all securities sought are tendered, the company would pay about $214.3 million from cash on hand, compared with the approximately $223 million it reported holding.
Bastion agreed to tender all its shares, pre-funded warrants and stapled warrants, and to a three-year standstill.
Cash and cryptocurrency stapled warrants are added at $0.17 each, with purchases of up to 100% of each class.
Pre-funded warrant purchases rise to 100% of each class from 95%, at $3.00 per warrant less the $0.0001 exercise price.
The company sold about 2 million SOL and no longer holds any SOL; the offer expires one minute after 11:59 p.m. New York time on November 12, 2026.
The Trust declared a monthly cash distribution of $0.045191 per unit, totaling $2,106,330.04, payable November 16, 2026 to holders of record on October 30, 2026. The payment rose from the prior month mainly due to a final settlement payment from Blackbeard Operating, but it includes no Waddell Ranch proceeds because those properties remain in an excess cost position, and a proposed combination with Blackbeard Holdings still requires a unitholder vote.
Distribution of $0.045191 per unit, or $2,106,330.04 across 46,608,796 units, payable November 16, 2026 to holders of record October 30, 2026.
Increase from the prior month due primarily to the final settlement payment from Blackbeard Operating; higher Texas Royalty Properties gas volumes and pricing also contributed, partly offset by lower oil pricing.
Waddell Ranch production costs exceeded gross proceeds for September 2026, so no Waddell Ranch proceeds were included; all excess costs plus accrued interest must be recovered before future distributions.
SoftVest's combination agreement dated July 28, 2026 proposes creating PBT Land and Minerals, Inc.; completion requires a Trust unitholder vote, and the Trustee is not making a recommendation.
Permianville Royalty Trust announced a cash distribution of $0.015 per unit, payable November 13, 2026, to unitholders of record on October 30, 2026. Oil receipts fell $0.8 million on a lower average oil price, while natural gas receipts rose $1.2 million, and the sponsor withheld an additional $0.3 million for a development reserve that now totals $2.0 million.
Distribution of $0.015 per unit; record date October 30, 2026; payable November 13, 2026.
Oil receipts totaled $3.1 million at $81.06 per barrel, down $0.8 million from the prior month, when the average price was $92.96 per barrel.
Natural gas receipts totaled $2.4 million at $3.05 per Mcf, up $1.2 million, helped in part by three newly drilled Haynesville wells.
COERT Holdings 1 LLC withheld an additional $0.3 million from current net profits, bringing its development reserve to $2.0 million.
SkyAI commenced on October 16, 2026, a cash tender offer to buy up to 95% of each class of its common stock and warrants at $3.00 per share or warrant, with the offer set to expire on October 29, 2026 unless extended. If fully subscribed, the purchase would cost about $201.3 million, paid from cash on hand of about $223.8 million as of October 16, 2026. For shareholders, the offer gives an option to sell for cash at a price the company says is about 0.95 times its net asset value, but it would use most of the company's cash.
Offer expires at one minute after 11:59 p.m. New York City time on October 29, 2026, unless extended or terminated early
Seeks up to 48,311,489 common shares, 4,880,734 cash pre-funded warrants, 9,939,850 cryptocurrency pre-funded warrants and 3,955,293 strategic warrants
Company held about $223.8 million in cash as of October 16, 2026, and has sold all of its SOL; the offer has no financing condition
Each class is conditioned on at least 50% of that class being tendered; the Board approved the offer but makes no recommendation to holders
SkyAI, Inc. said it will begin its previously announced cash tender offer on October 15, 2026, when it files a Schedule TO with the SEC after market close. The offer seeks up to 95% of each class of shares and warrants at $3.00 each, a price the company says is a 65% premium to its October 9, 2026 closing share price, and the company expects to hold no SOL once the offer is completed.
Purchase price of $3.00 per share or warrant in cash, a 65% premium to the October 9, 2026 closing share price
Offer expires at one minute after 11:59 p.m. New York City time on October 29, 2026, unless extended or terminated earlier
As of October 14, 2026, the company held about $204.6 million in cash and about 210,000 locked SOL, and sold SOL at an average of $107.51 net of fees
At a special meeting on October 6, 2026, stockholders approved raising authorized common stock from 250,000,000 to 275,000,000 shares and approved issuing common stock on conversion of Series C preferred stock and warrants, which the filing says could exceed 20% of outstanding shares and may, with management and board changes, result in a change of control. The filing body names Quince Therapeutics, Inc. while the header lists IRulya Therapeutics Inc., so the registrant identity should be confirmed. For shareholders, the approvals add capacity for potential dilution and a possible change in control.
Authorized common stock increased from 250,000,000 to 275,000,000 shares, effective October 6, 2026
Proposal 2 passed with 343,517 votes for and 5,759 against; Proposal 1 passed with 180,550 votes for and 5,742 against
Proposal 1 may result in a change of control under Nasdaq Listing Rule 5635(b)
2026 Equity Incentive Plan reserve starts at 821,872 shares; 2026 ESPP reserve starts at 142,045 shares
MacKenzie Realty Capital, Inc. temporarily suspended its preferred Dividend Reinvestment Program (DRIP) and its preferred share repurchase program while it reviews strategic alternatives brought by its financial advisor, Maxim Group LLC. The pending October dividend will be paid fully in cash, including to holders who had elected DRIP participation, and the Board approved regular preferred dividends for the quarter ending December 31, 2026, at the same amounts as previous quarters. Preferred holders lose the reinvestment and repurchase options for now, and the company states there is no assurance that any strategic transaction will result.
DRIP suspended for this cycle; the October dividend is paid entirely in cash, including to enrolled DRIP participants, per the October 2, 2026 letter.
Preferred share repurchase program temporarily suspended while the company reviews strategic alternatives from Maxim Group LLC; the company says there can be no assurance of a strategic transaction.
Board approved monthly dividends of $0.125 per Series A share, $0.0625 per Series B share and $0.1875 per Series C share for holders of record on October 31, November 30 and December 31, 2026, payable in January 2027.
DRIP intended to resume after the SEC qualifies the amended Offering Circular, with no new election required from enrolled participants.
MacKenzie Realty Capital reported fiscal 2026 results for the year ended June 30, 2026, with net revenues down 9% and net loss down 41%. The same day, its Board temporarily suspended the Preferred Share Repurchase Program so it can react to strategic alternatives that its financial advisor, Maxim Group LLC, may bring. The Board says the company's issuance of common stock in exchange for preferred shares added selling pressure on the common stock, and it expects to reassess the program in due course.
Net revenues were $20.01 million for fiscal 2026, down 9% from $22.06 million in fiscal 2025.
Net loss was $14.13 million, down 41% from $23.97 million; net operating loss was $15.61 million, down 33% from $23.46 million.
The Preferred Share Repurchase Program is temporarily suspended; the Board expects to reassess it in due course.
The company says there can be no assurance that it will enter into any strategic transaction.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.